AQR Arbitrage’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-100,000
Closed -$1.04M 863
2023
Q2
$1.04M Hold
100,000
0.05% 353
2023
Q1
$1.02M Sell
100,000
-288,080
-74% -$2.93M 0.03% 426
2022
Q4
$3.97M Hold
388,080
0.1% 279
2022
Q3
$3.88M Hold
388,080
0.09% 326
2022
Q2
$3.87M Sell
388,080
-200
-0.1% -$1.97K 0.09% 305
2022
Q1
$3.81M Sell
388,280
-211,718
-35% -$2.08M 0.1% 244
2021
Q4
$5.88M Buy
+599,998
New +$5.86M 0.15% 149

Other funds holding PEPL

AQR Arbitrage's PEPL Position: Q3 2023 in Review

AQR Arbitrage sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q3 2023, closing a stake of 100,000 shares — an estimated $1.04M sold.

AQR Arbitrage first reported a position in PEPL in Q4 2021 and held it in 7 quarters. The position peaked at $5.88M in Q4 2021. 11 funds tracked by Wall St. Rank hold PEPL as of Q3 2023.

  • AQR Arbitrage reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q3 2023 after selling out during the quarter.
  • AQR Arbitrage sold 100,000 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q3 2023, an estimated $1.04M.
  • AQR Arbitrage first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 7 quarters.
  • AQR Arbitrage's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $5.88M in Q4 2021.
  • 11 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q3 2023.

Based on AQR Arbitrage's 13F filing for Q3 2023, filed 14 Nov 2023.